IBA signs contract for a Proteus®ONE proton therapy system to be located at the Greater Poland Cancer Center
21 Dezembro 2023 - 3:00AM
IBA signs contract for a Proteus®ONE proton therapy system to be
located at the Greater Poland Cancer Center
Louvain-La-Neuve, Belgium, December 21,
2023 – IBA (Ion Beam Applications S.A., EURONEXT), the
world leader in particle accelerator technology and the world’s
leading provider of proton therapy solutions for the treatment of
cancer, today announces it has signed a contract with Health
Technologies Sp. z o.o. (Health Technologies) for the supply of a
Proteus®ONE1 compact proton therapy system to be delivered at the
Greater Poland Cancer Center (Wielkopolskie Centrum Onkologii) in
Poznan, Poland. The downpayment has been received.
The contract includes the supply of a
Proteus®ONE system, equipped with the Philips Ambient Experience
solution to enhance the care environment and patient comfort during
treatment. Proteus®ONE is the market leading compact proton therapy
system, upgradable over time to continue to offer the latest
technology to IBA users.
Health Technologies was recently selected by the
Greater Poland Cancer Center following a competitive public tender
process for the supply of a compact proton therapy system. The
publicly disclosed winning bid by Health Technologies in the tender
process was EUR 25,100,000.
Olivier Legrain, Chief Executive Officer
of IBA, commented: “This new contract marks the first sale
of a Proteus®ONE solution in Poland, and will be the second IBA
proton therapy system in the country, demonstrating IBA’s strong
position to meet the growing demand for proton therapy technology
in central Europe. We are pleased to see projects like these, which
will enable a greater number of cancer patients to benefit from
this cutting-edge technology in the region.”
Professor Julien Malicki, Director of
the Greater Poland Cancer Center, added: “As for the
result of the tender we look forward to working with Health
Technologies and IBA to offer proton therapy technology to our
patients. It is a significant step in developing highly specialized
cancer treatment in Poznan by adding new methods.”
***ENDS***
About IBA
IBA (Ion Beam Applications S.A.) is the world
leader in particle accelerator technology. The company is the
leading supplier of equipment and services in the field of proton
therapy, considered to be the most advanced form of radiation
therapy available today. IBA is also a leading player in the fields
of industrial sterilization, radiopharmaceuticals and dosimetry.
The company, based in Louvain-la-Neuve, Belgium, employs
approximately 1,800 people worldwide. IBA is a certified B
Corporation (B Corp) meeting the highest standards of verified
social and environmental performance.
IBA is listed on the pan-European stock exchange
EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at:
www.iba-worldwide.com
About The Greater Poland Cancer Center / Wielkopolskie
Centrum Onkologii
The Maria Skłodowska–Curie Greater Poland Cancer
Center is a highly specialised medical centre located in Poznań,
the heart of the Wielkopolska (Greater Poland) region, that
provides a full combined cancer therapy: surgery, radiotherapy and
chemotherapy. Annually, the center receives over 20,000 inpatients,
performs nearly 7,000 surgeries and over 13,000 cytostatic
treatments, and administers ionizing radiation procedures to nearly
6,000 patients.
Health Technologies Sp. z o.o.
Established in 2012, Health Technologies
specializes in distribution medical devices and equipment in the
field of radiotherapy, nuclear medicine, and other healthcare
sectors. Health Technology also represents in Poland world renowned
brands such as IBA Dosimetry, IBA RadioPharma Solutions, CQ Medical
and Spectrum Dynamics Medical.
CONTACTS
Soumya
ChandramouliChief Financial Officer+32 10
475 890Investorrelations@iba-group.com
Olivier LechienCorporate
Communication Director+32 10 475 890communication@iba-group.com
ICR Consilium Amber Fennell,
Matthew Neal, Lucy Featherstone+44 (0) 20 3709
5700IBA@consilium-comms.com
1 Proteus®ONE is the brand name of Proteus®235
- 231221_IBA-ProteusONE-Poznan-Poland-EN
Ion Beam Applications (EU:IBAB)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Ion Beam Applications (EU:IBAB)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
